An overview of systematic reviews of economic evaluations of pharmacy-based public health interventions: addressing methodological challenges

[1]  P. Tugwell,et al.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.

[2]  Z. Babar,et al.  Economic Evaluation of Hospital and Community Pharmacy Services , 2017, The Annals of pharmacotherapy.

[3]  O. Bugnon,et al.  Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. , 2016, Health policy.

[4]  H. Wee,et al.  Humanistic and economic outcomes of pharmacist‐provided medication review in the community‐dwelling elderly: A systematic review and meta‐analysis , 2016, Journal of clinical pharmacy and therapeutics.

[5]  V. García-Cárdenas,et al.  Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review , 2016, Expert review of pharmacoeconomics & outcomes research.

[6]  Y. Ko,et al.  Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[7]  F. Sniehotta,et al.  Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation , 2016, BMJ Open.

[8]  T. Greenhalgh,et al.  Explaining high and low performers in complex intervention trials: a new model based on diffusion of innovations theory , 2015, Trials.

[9]  T. Salgado,et al.  Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010) , 2015, International Journal of Clinical Pharmacy.

[10]  A. O’Cathain,et al.  Process evaluation of complex interventions: Medical Research Council guidance , 2015, BMJ : British Medical Journal.

[11]  R. Willke,et al.  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  K. Putman,et al.  A Review of the Methodological Challenges in Assessing the Cost Effectiveness of Pharmacist Interventions , 2014, PharmacoEconomics.

[13]  Stuart W. Turner,et al.  Economic Evaluations of Clinical Pharmacy Services: 2006–2010 , 2014, Pharmacotherapy.

[14]  N. D. de Vries,et al.  A review of economic evaluations of behavior change interventions: setting an agenda for research methods and practice. , 2014, Journal of public health.

[15]  L. Mayberry,et al.  Empirical Validation of the Information–Motivation–Behavioral Skills Model of Diabetes Medication Adherence: A Framework for Intervention , 2014, Diabetes Care.

[16]  D. Pieper,et al.  Systematic review finds overlapping reviews were not mentioned in every other overview. , 2014, Journal of clinical epidemiology.

[17]  R. Edwards,et al.  Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues , 2013, BMC Public Health.

[18]  H. Naci,et al.  Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? , 2013, Health policy.

[19]  D. Fitzsimmons,et al.  A Systematic Review of the Clinical and Economic Effectiveness of Clinical Pharmacist Intervention in Secondary Prevention of Cardiovascular Disease , 2013, Journal of managed care pharmacy : JMCP.

[20]  S. Blalock,et al.  The Effect of Community Pharmacy–Based Interventions on Patient Health Outcomes , 2013, Medical care research and review : MCRR.

[21]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  K. Marsh,et al.  Estimating cost-effectiveness in public health: a summary of modelling and valuation methods , 2012, Health Economics Review.

[23]  J. Taggart,et al.  Which providers can bridge the health literacy gap in lifestyle risk factor modification education: a systematic review and narrative synthesis , 2012, BMC Family Practice.

[24]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[25]  Stavros Petrou,et al.  Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[26]  M. Clarke,et al.  Methodology in conducting a systematic review of systematic reviews of healthcare interventions , 2011, BMC medical research methodology.

[27]  J. Graff Zivin,et al.  US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses , 2010, Medical care.

[28]  Ivo Abraham,et al.  Economic effects of pharmacists on health outcomes in the United States: A systematic review. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[29]  K. Lawson,et al.  Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach? , 2010, International journal of environmental research and public health.

[30]  Karl Claxton,et al.  Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. , 2009, Health policy.

[31]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[32]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[33]  M. Drummond,et al.  Explicit incorporation of equity considerations into economic evaluation of public health interventions , 2009, Health Economics, Policy and Law.

[34]  Stuart W. Turner,et al.  Economic Evaluations of Clinical Pharmacy Services: 2001–2005 , 2009, Pharmacotherapy.

[35]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[36]  M. Drummond,et al.  Incorporating economics evidence , 2008 .

[37]  Richard Cooke,et al.  How well do the theory of reasoned action and theory of planned behaviour predict intentions and attendance at screening programmes? A meta-analysis , 2008, Psychology & health.

[38]  Kylie A. Williams,et al.  Practice Change in Community Pharmacy: Quantification of Facilitators , 2008, The Annals of pharmacotherapy.

[39]  J. Hiller,et al.  Applicability and transferability of interventions in evidence-based public health. , 2006, Health promotion international.

[40]  B. Arondekar,et al.  Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000 , 2003, Pharmacotherapy.

[41]  G. Schumock.  Methods to Assess the Economic Outcomes of Clinical Pharmacy Services , 2000, Pharmacotherapy.

[42]  G. Schumock.  Methods to assess the humanistic outcomes of clinical pharmacy services. , 2000 .

[43]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[44]  J L Bootman,et al.  Drug-related morbidity and mortality and the economic impact of pharmaceutical care. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[45]  G. Schumock,et al.  Economic Evaluations of Clinical Pharmacy Services—1988–1995 , 1996, Pharmacotherapy.

[46]  W. Mcghan,et al.  Principles of Pharmacoeconomics , 1990 .

[47]  Jennifer A. Whitty,et al.  Design Principles for Economic Evaluations in Pharmacy , 2017 .

[48]  C. Jommi.  An Introduction to Economic Evaluation of Health Care Programs , 2017 .

[49]  R. Kayyali,et al.  Smoking Cessation Support Services at Community Pharmacies in the UK: A Systematic Review. , 2016, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[50]  M. Petticrew,et al.  Developing and Evaluating Complex Interventions , 2015 .

[51]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[52]  Adrian E Bauman,et al.  Behavioral strategies in diabetes prevention programs: a systematic review of randomized controlled trials. , 2011, Diabetes research and clinical practice.

[53]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[54]  Marie Schmidt,et al.  HEAL TH AT A GLANCE , 2007 .

[55]  M. Drummond,et al.  Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[56]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..